Can biotechnology prevent another Walkerton?
The
future for E. coli vaccines
with
B. Brett Finlay
Biotechnology Laboratory, University of British Columbia.
Although we all contain harmless E. coli as part of our normal
intestinal flora, there are several strains of E. coli that
can cause much human disease worldwide. Pathogenic E. coli
O157:H7, the organism that caused the Walkerton outbreak,
is shed by cattle, and causes severe diarrhea and associated
kidney disease in humans.
Research in Dr. Finlay's lab has uncovered the fundamental
molecular processes used by the bacteria to highjack intestinal
cells and suggests ways to block and treat the disease. He
will discuss promising new vaccine studies in cattle, as well
as share his insights on how basic research contributes to
innovation in vaccines.
Dr. Brett Finlay obtained his Ph.D. in Biochemistry from
the University of Alberta. He conducted his postdoctoral research
in Dr. Stanley Falkow's laboratory at Stanford University.
He is currently a professor at the University of British Columbia
(UBC) with the Biotechnology Laboratory, and the Departments
of Biochemistry and Molecular Biology, and Microbiology and
Immunology, as well as the UBC Peter Wall Distinguished Professor,
a CIHR Distinguished Investigator and a Howard Hughes Medical
Institute International Research Scholar.
Simultaneous translation will be provided.
Co-Sponsors:
--the Speaker of the Senate, the Hon. Daniel Hays
--the Speaker of the House of Commons, the Hon. Peter Milliken
--Partnership Group for Science and Engineering (PAGSE)
--NSERC
DATE: Thursday, February 13, 2003 from 7:30 am - 9:00 am
|
